Wenqing Yao,Jincong Zhuo,Meizhong Xu,Fenglei Zhang,Brian W. Metcalf
申请号：
US15204423
公开号：
US20170035751A1
申请日:
2016.07.07
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention provides a compound of Formula I or Formula II:enantiomer, diastereomer, prodrug, solvate, metabolite, or pharmaceutically acceptable salt thereof, wherein constituent variables are provided herein. The compounds of Formula I and II are modulators of metalloproteases and are useful in treating diseases associated with metalloprotease activity such as arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions.
